The Quest for Ovarian Cancer's Holy Grail: Can CA-125 Still Be the Chalice of Early Detection?-Reference-Cited by-同舟云学术

The Quest for Ovarian Cancer's Holy Grail: Can CA-125 Still Be the Chalice of Early Detection?

Published:2007-04-10 Issue:11 Volume:25 Page:1303-1304
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Karlan Beth Y.¹,McIntosh Martin²

Affiliation:

1. Women's Cancer Research Institute; Division of Gynecologic Oncology, Cedars-Sinai Medical Center; Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA

2. Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, WA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2006.09.7543

Reference14 articles.

1. Serum CA-125 in Relation to Adnexal Dysplasia and Cancer in Women at Hereditary High Risk of Ovarian Cancer

2. Pauler DK, Menon U, McIntosh M, et al: Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev 10:489,2001-493,

3. Ovarian cancer screening

4. Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers

5. McIntosh MW, Urban N, Karlan B: Generating longitudinal screening algorithms using novel biomarkers for disease. Cancer Epidemiol Biomarkers Prev 11:159,2002-166,

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aptamer-based silver nanoparticle decorated paper platform for electrochemical detection ovarian cancer biomarker PDGF;Materials Chemistry and Physics;2023-09

2. Use of CA125 and HE4 Serum Markers to Predict Ovarian Cancer in Elevated-Risk Women;Cancer Epidemiology Biomarkers & Prevention;2014-05-01

3. Label-free detection of ovarian cancer biomarkers using whispering gallery mode imaging;Biosensors and Bioelectronics;2013-07

4. Programmable Bio-Nano-Chip Systems for Serum CA125 Quantification: Toward Ovarian Cancer Diagnostics at the Point-of-Care;Cancer Prevention Research;2012-04-09

5. SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance;Gynecologic Oncology;2010-10